A randomised controlled trial to evaluate topical 10% metronidazole ointment for the treatment of perianal Crohn's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN54256247

Enrollment

Registered

2005-09-30

Start date

2004-06-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease Digestive System Crohn's disease [regional enteritis]

Interventions

This is a randomised, double blind, placebo-controlled, parallel group clinical trial comparing placebo and 10% metronidazole ointment for the treatment of perianal Crohn's disease.

Eligibility

Inclusion criteria

Inclusion criteria: 30 patients with peri-anal Crohn's disease will be recruited throughout the course of the trial.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Secondary

Measure	Time frame
Not provided at time of registration	—

Primary

Measure	Time frame
Peri-anal Crohn's disease activity index.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026